• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在卡介苗中用重组痘苗病毒对优化后的 HIV-1 CRF01_AE Gag 进行原核增强免疫,可在小鼠中引发 MHC Ⅰ类和Ⅱ类免疫应答。

Prime-boost immunization of codon optimized HIV-1 CRF01_AE Gag in BCG with recombinant vaccinia virus elicits MHC class I and II immune responses in mice.

机构信息

Department of Medical Sciences, Ministry of Public Health, Muang, Nonthaburi, Thailand.

出版信息

Immunol Invest. 2009;38(8):762-79. doi: 10.3109/08820130903070544.

DOI:10.3109/08820130903070544
PMID:19860587
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9491105/
Abstract

The HIV-1 CRF01_AE gag gene was modified by codon restriction for Mycobacterium spp. and transformed into BCG; and it was designated as rBCG/codon optimized gagE. This produced 11 fold higher HIV-1 gag protein expression than the recombinant native gene rBCG/HIV-1gagE. In mice, CTL activity could be induced either by a single immunization of the codon optimized construct or by using it as a priming antigen in the prime-boost modality with recombinant Vaccinia virus expressing native HIV-1 gag. Specific secreted cytokine responses were also investigated. Only when rBCG gag was codon optimized did the prime-boost immunization produce significantly enhanced IFN-gamma and IL-2 secretion indicating recognition via CD4+ and CD8+ T cells, and these responses seemed to be codon optimized immunogen dose-responsive. On contrary, the prime-boost vaccination using an equal amount of native rBCG/HIV-1gagE instead, or a single rBCG/codon optimized gagE immunization, had no similar effect on the cytokine secretion. These findings suggest that the use of recombinant codon BCG construct with recombinant Vaccinia virus encoding CRF01_AE gag as the prime-boost HIV vaccine candidate, will induce CD4+ Th1 and CD8+ T cell cytokine secretions in addition to enhancing CD8+ CTL response.

摘要

HIV-1 CRF01_AE 的 gag 基因经过密码子限制修饰后转入 BCG,命名为 rBCG/codon 优化 gagE。与重组天然基因 rBCG/HIV-1gagE 相比,该基因表达 HIV-1 gag 蛋白的能力提高了 11 倍。在小鼠中,单次免疫编码优化构建体或使用其作为重组痘苗病毒表达天然 HIV-1 gag 的初免-加强免疫模式的启动抗原,均可诱导 CTL 活性。还研究了特异性分泌细胞因子的反应。只有当 rBCG gag 进行密码子优化时,初免-加强免疫才会显著增强 IFN-γ和 IL-2 的分泌,表明通过 CD4+和 CD8+T 细胞识别,并且这些反应似乎与密码子优化免疫原的剂量呈正相关。相反,使用等量的天然 rBCG/HIV-1gagE 替代初免-加强免疫,或单独使用 rBCG/codon 优化 gagE 免疫,对细胞因子分泌没有类似的影响。这些发现表明,使用重组密码子 BCG 构建体和编码 CRF01_AE gag 的重组痘苗病毒作为初免-加强 HIV 疫苗候选物,除了增强 CD8+CTL 反应外,还会诱导 CD4+Th1 和 CD8+T 细胞细胞因子的分泌。

相似文献

1
Prime-boost immunization of codon optimized HIV-1 CRF01_AE Gag in BCG with recombinant vaccinia virus elicits MHC class I and II immune responses in mice.在卡介苗中用重组痘苗病毒对优化后的 HIV-1 CRF01_AE Gag 进行原核增强免疫,可在小鼠中引发 MHC Ⅰ类和Ⅱ类免疫应答。
Immunol Invest. 2009;38(8):762-79. doi: 10.3109/08820130903070544.
2
Prime-boost vaccination using recombinant Mycobacterium bovis BCG and recombinant vaccinia virus DIs harboring HIV-1 CRF01_AE gag in mice: influence of immunization routes.在小鼠中使用重组牛分枝杆菌卡介苗和携带HIV-1 CRF01_AE gag的重组痘苗病毒DIs进行初免-加强免疫接种:免疫途径的影响
Southeast Asian J Trop Med Public Health. 2009 Mar;40(2):273-81.
3
Priming with a recombinant pantothenate auxotroph of Mycobacterium bovis BCG and boosting with MVA elicits HIV-1 Gag specific CD8+ T cells.用重组泛酸营养缺陷型牛分枝杆菌卡介苗(BCG)进行初始免疫,并用 MVA 进行加强免疫,可引发 HIV-1 Gag 特异性 CD8+ T 细胞。
PLoS One. 2012;7(3):e32769. doi: 10.1371/journal.pone.0032769. Epub 2012 Mar 29.
4
HIV-1 Subtype C Mosaic Gag Expressed by BCG and MVA Elicits Persistent Effector T Cell Responses in a Prime-Boost Regimen in Mice.卡介苗(BCG)和痘苗病毒 Ankara 株(MVA)表达的 HIV-1 C 亚型嵌合 gag 在小鼠的初免-加强免疫方案中引发持续的效应 T 细胞反应。
PLoS One. 2016 Jul 18;11(7):e0159141. doi: 10.1371/journal.pone.0159141. eCollection 2016.
5
Robust immunity to an auxotrophic Mycobacterium bovis BCG-VLP prime-boost HIV vaccine candidate in a nonhuman primate model.在非人灵长类动物模型中,对营养缺陷型牛分枝杆菌 BCG-VLP 初免-加强 HIV 疫苗候选物产生稳健的免疫应答。
J Virol. 2013 May;87(9):5151-60. doi: 10.1128/JVI.03178-12. Epub 2013 Feb 28.
6
Priming with recombinant auxotrophic BCG expressing HIV-1 Gag, RT and Gp120 and boosting with recombinant MVA induces a robust T cell response in mice.用表达 HIV-1 Gag、RT 和 Gp120 的重组营养缺陷型卡介苗进行初始免疫,并用重组 MVA 进行加强免疫,可在小鼠中诱导出强烈的 T 细胞应答。
PLoS One. 2013 Aug 20;8(8):e71601. doi: 10.1371/journal.pone.0071601. eCollection 2013.
7
Development of a Live Recombinant BCG Expressing Human Immunodeficiency Virus Type 1 (HIV-1) Gag Using a pMyong2 Vector System: Potential Use As a Novel HIV-1 Vaccine.使用 pMyong2 载体系统构建表达人类免疫缺陷病毒 1 型(HIV-1)Gag 的活重组卡介苗:作为新型 HIV-1 疫苗的潜在用途。
Front Immunol. 2018 Mar 27;9:643. doi: 10.3389/fimmu.2018.00643. eCollection 2018.
8
Immunogenicity and safety of the vaccinia virus LC16m8Δ vector expressing SIV Gag under a strong or moderate promoter in a recombinant BCG prime-recombinant vaccinia virus boost protocol.在重组卡介苗初免-重组痘苗病毒加强方案中,在强启动子或中强度启动子控制下表达猴免疫缺陷病毒(SIV)Gag的痘苗病毒LC16m8Δ载体的免疫原性和安全性。
Vaccine. 2013 Aug 2;31(35):3549-57. doi: 10.1016/j.vaccine.2013.05.071. Epub 2013 May 31.
9
Preferential Targeting of Conserved Gag Regions after Vaccination with a Heterologous DNA Prime-Modified Vaccinia Virus Ankara Boost HIV-1 Vaccine Regimen.用异源DNA初免-改良安卡拉痘苗病毒加强的HIV-1疫苗方案接种后对保守的Gag区域的优先靶向作用
J Virol. 2017 Aug 24;91(18). doi: 10.1128/JVI.00730-17. Print 2017 Sep 15.
10
Recombinant Mycobacterium bovis bacillus Calmette-Guerin elicits human immunodeficiency virus type 1 envelope-specific T lymphocytes at mucosal sites.重组卡介苗在黏膜部位引发1型人类免疫缺陷病毒包膜特异性T淋巴细胞。
Clin Vaccine Immunol. 2007 Jul;14(7):886-93. doi: 10.1128/CVI.00407-06. Epub 2007 May 16.

引用本文的文献

1
Unleashing the power of the BCG vaccine in modulating viral immunity through heterologous protection: A scoping review.通过异源保护释放卡介苗疫苗在调节病毒免疫方面的潜力:一项范围综述。
Hum Vaccin Immunother. 2025 Dec;21(1):2521190. doi: 10.1080/21645515.2025.2521190. Epub 2025 Jul 3.
2
Recombinant BCG-Based HIV Vaccine: Failures and Promising Approaches for a Successful Vaccine Strategy.基于重组卡介苗的HIV疫苗:成功疫苗策略的失败与前景方法
Vaccines (Basel). 2025 Jun 3;13(6):606. doi: 10.3390/vaccines13060606.
3
Role for Gr-1+ cells in the control of high-dose Mycobacterium bovis recombinant BCG.Gr-1+细胞在控制高剂量牛分枝杆菌重组卡介苗中的作用。
Clin Vaccine Immunol. 2014 Aug;21(8):1120-7. doi: 10.1128/CVI.00363-14. Epub 2014 Jun 11.

本文引用的文献

1
Enhancement of cell-mediated immune response in mice by whole HIV-1 gag in Mycobacterium bovis BCG as a live vaccine candidate.牛分枝杆菌卡介苗作为候选活疫苗,其携带的完整HIV-1 gag增强小鼠细胞介导的免疫反应。
Southeast Asian J Trop Med Public Health. 2009 Jan;40(1):113-22.
2
Prime-boost vaccination using recombinant Mycobacterium bovis BCG and recombinant vaccinia virus DIs harboring HIV-1 CRF01_AE gag in mice: influence of immunization routes.在小鼠中使用重组牛分枝杆菌卡介苗和携带HIV-1 CRF01_AE gag的重组痘苗病毒DIs进行初免-加强免疫接种:免疫途径的影响
Southeast Asian J Trop Med Public Health. 2009 Mar;40(2):273-81.
3
Vaccine platform for prevention of tuberculosis and mother-to-child transmission of human immunodeficiency virus type 1 through breastfeeding.通过母乳喂养预防结核病和1型人类免疫缺陷病毒母婴传播的疫苗平台。
J Virol. 2007 Sep;81(17):9408-18. doi: 10.1128/JVI.00707-07. Epub 2007 Jun 27.
4
Codon optimization of the tat antigen of human immunodeficiency virus type 1 generates strong immune responses in mice following genetic immunization.1型人类免疫缺陷病毒tat抗原的密码子优化在基因免疫后可在小鼠体内产生强烈的免疫反应。
J Virol. 2004 Sep;78(17):9174-89. doi: 10.1128/JVI.78.17.9174-9189.2004.
5
Induction of CD8+ T cells to an HIV-1 antigen through a prime boost regimen with heterologous E1-deleted adenoviral vaccine carriers.通过使用异源E1缺失腺病毒疫苗载体的初免-加强方案诱导CD8 + T细胞针对HIV-1抗原的反应。
J Immunol. 2003 Dec 15;171(12):6774-9. doi: 10.4049/jimmunol.171.12.6774.
6
A new mutant of dermovaccinia virus.一种新的皮肤痘苗病毒突变体。
Nature. 1961 Oct 28;192:381-2. doi: 10.1038/192381a0.
7
Comparative immunogenicity in rhesus monkeys of DNA plasmid, recombinant vaccinia virus, and replication-defective adenovirus vectors expressing a human immunodeficiency virus type 1 gag gene.表达1型人类免疫缺陷病毒gag基因的DNA质粒、重组痘苗病毒和复制缺陷型腺病毒载体在恒河猴中的免疫原性比较
J Virol. 2003 Jun;77(11):6305-13. doi: 10.1128/jvi.77.11.6305-6313.2003.
8
CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes.CD4+ T细胞是CD8+ T淋巴细胞二次扩增和记忆所必需的。
Nature. 2003 Feb 20;421(6925):852-6. doi: 10.1038/nature01441. Epub 2003 Feb 9.
9
Structural analysis of vaccinia virus DIs strain: application as a new replication-deficient viral vector.痘苗病毒缺陷干扰株的结构分析:作为一种新型复制缺陷型病毒载体的应用
Virology. 2002 Oct 25;302(2):433-44. doi: 10.1006/viro.2002.1622.
10
Multiple effects of codon usage optimization on expression and immunogenicity of DNA candidate vaccines encoding the human immunodeficiency virus type 1 Gag protein.密码子使用优化对编码人免疫缺陷病毒1型Gag蛋白的DNA候选疫苗的表达和免疫原性的多种影响。
J Virol. 2001 Nov;75(22):10991-1001. doi: 10.1128/JVI.75.22.10991-11001.2001.